Generate Biomedicines is trading at $13.07, up 0.1% versus the October 15 close of $13.06; no clear company-specific catalyst was identified for the pre-market move. - The Zealand Pharma collaboration was announced October 13, but available reporting does not connect it to October 16 trading. - Generate Biomedicines’ October 15 close was up 4.31%; that prior-session gain does not establish the reason for the pre-market price. - Broader market indicators are modestly positive, without a clear market-wide move explaining the change.